Literature DB >> 2761600

Weight, diet, and the risk of symptomatic gallstones in middle-aged women.

K M Maclure1, K C Hayes, G A Colditz, M J Stampfer, F E Speizer, W C Willett.   

Abstract

To assess the risk factors for symptomatic gallstones, 88,837 women in the Nurses' Health Study cohort (age range, 34 to 59 years) were followed for four years after completing a detailed questionnaire about food and alcohol intake in 1980. A total of 433 cholecystectomies and 179 cases of newly symptomatic, unremoved gallstones, diagnosed by ultrasonographic examination or x-ray films, were reported during the four-year follow-up. The age-adjusted relative risk for very obese women, who had a Quetelet index of relative weight (weight in kilograms divided by the square of the height in meters) of more than 32 kg per square meter, was 6.0 (95 percent confidence interval, 4.0 to 9.0), as compared with women whose relative weight was less than 20 kg per square meter. For slightly overweight women (relative weight, 24 to 24.9 kg per square meter), the relative risk was 1.7 (95 percent confidence interval, 1.1 to 2.7). Overall, we observed a roughly linear relation between relative weight and the risk of gallstones. Among the 59,306 women whose relative weight was less than 25 kg per square meter, a high energy intake (greater than 8200 J per day), as compared with a low energy intake (less than 4730 J per day), was associated with an increased incidence of symptomatic gallstones (relative risk, 2.1; 95 percent confidence interval, 1.4 to 3.3), and an alcohol intake of at least 5 g per day was associated with a decreased incidence as compared with abstention (relative risk, 0.6; 95 percent confidence interval, 0.4 to 0.8). Parity did not appear to be an important risk factor after an adjustment was made for relative weight. These data support a strong association between obesity and symptomatic gallstones and suggest that even moderate overweight may increase the risk.

Entities:  

Mesh:

Year:  1989        PMID: 2761600     DOI: 10.1056/NEJM198908313210902

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  67 in total

Review 1.  Fortnightly review: gallbladder disease.

Authors:  M C Bateson
Journal:  BMJ       Date:  1999-06-26

Review 2.  Cholesterol gallstones: from epidemiology to prevention.

Authors:  M Acalovschi
Journal:  Postgrad Med J       Date:  2001-04       Impact factor: 2.401

Review 3.  The diet and cancer hypothesis: current trends.

Authors:  R Saracci
Journal:  Med Oncol Tumor Pharmacother       Date:  1990

4.  Determinants of gallbladder kinetics in obesity.

Authors:  E M H Mathus-Vliegen; M L Van Ierland-Van Leeuwen; A Terpstra
Journal:  Dig Dis Sci       Date:  2004-01       Impact factor: 3.199

5.  ABO blood group and gall stone disease.

Authors:  T Juvonen; O Niemelä
Journal:  BMJ       Date:  1992-07-04

6.  Challenges for public health nutrition in the 1990s.

Authors:  W Willett
Journal:  Am J Public Health       Date:  1990-11       Impact factor: 9.308

Review 7.  Diet, alcohol, and gout: how do we advise patients given recent developments?

Authors:  Hyon K Choi
Journal:  Curr Rheumatol Rep       Date:  2005-06       Impact factor: 4.592

8.  Pediatric obesity and gallstone disease.

Authors:  Corinna Koebnick; Ning Smith; Mary Helen Black; Amy H Porter; Bradley A Richie; Sharon Hudson; Deborah Gililland; Steven J Jacobsen; George F Longstreth
Journal:  J Pediatr Gastroenterol Nutr       Date:  2012-09       Impact factor: 2.839

9.  A prospective study of hospitalization with gallstone disease among women: role of dietary factors, fasting period, and dieting.

Authors:  R Sichieri; J E Everhart; H Roth
Journal:  Am J Public Health       Date:  1991-07       Impact factor: 9.308

10.  Post Roux-en-Y gastric bypass biliary dilation: natural process or significant entity?

Authors:  K El-Hayek; P Timratana; J Meranda; H Shimizu; S Eldar; B Chand
Journal:  J Gastrointest Surg       Date:  2012-10-26       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.